Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Joint Bone Spine|November 26, 2009
Primary Sjögren's syndrome: pathophysiological, clinical and therapeutic advancesJ-E Gottenberg
Annals of the Rheumatic Diseases|August 21, 2008
Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activityS Candon, J E Gottenberg, D Bengoufa, et al.
La Revue De Medecine Interne|September 6, 2011
[Management of the risk of hepatitis B virus reactivation in patients receiving immunosuppressive and immunomodulatory agents in internal medicine: data from the REACTI-B survey and proposal for a management algorithm]B Terrier, S Pol, V Thibault, et al.
Scandinavian Journal of Immunology|January 19, 2008
B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndromeF Lavie, C Miceli-Richard, M Ittah, et al.
Clinical and Experimental Rheumatology|June 10, 2006
Leflunomide in rheumatoid arthritis in daily practice: treatment discontinuation rates in comparison with other DMARDsI Bettembourg-Brault, L Gossec, T Pham, et al.
RMD Open|October 29, 2015
ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?J Payet, R Belkhir, J E Gottenberg, et al.
Genes and Immunity|June 4, 2005
No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndromeM Ittah, J-E Gottenberg, A Proust, et al.
Rheumatology (Oxford, England)|February 26, 2008
Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome?J Sellam, C Miceli-Richard, J-E Gottenberg, et al.
Arthritis Care & Research|July 18, 2013
First-year radiographic progression as a predictor of further progression in early arthritis: results of a large national French cohortGabriel Tobón, Alain Saraux, Cedric Lukas, et al.
Clinical Rheumatology|January 21, 2022
Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treatL Widawski, T Fabacher, L Spielmann, et al.
Pageof 4